Tag: Ascendis Pharma

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Ascendis Pharma

Ascendis Pharma (NASDAQ:ASND) Upgraded to “Strong-Buy” by ValuEngine

Added to Collection on: 2018-05-17 19:37:30

Tags for this article:

Pharma
Ascendis Pharma

Click the tags to see associated articles and topics

View Article Details
Ascendis Pharma (ASND) Lifted to Strong-Buy at ValuEngine

Added to Collection on: 2018-05-19 15:18:45

Tags for this article:

Ascendis Pharma

Click the tags to see associated articles and topics

View Article Details
Ascendis Pharma (ASND) Lifted to “Strong-Buy” at ValuEngine

Added to Collection on: 2018-05-20 16:03:25

Tags for this article:

Pharma
Ascendis Pharma

Click the tags to see associated articles and topics

View Article Details
Ascendis Pharma (ASND) Given Consensus Rating of “Buy” by Analysts

Added to Collection on: 2018-05-21 05:33:22

Tags for this article:

Pharma
Ascendis Pharma

Click the tags to see associated articles and topics

View Article Details
Ascendis Pharma (NASDAQ:ASND) Short Interest Update

Added to Collection on: 2018-05-22 06:18:45

Tags for this article:

Money
Finance
Economy
Stock
Short
Financial regulation
Ascendis Pharma

Click the tags to see associated articles and topics

View Article Details
Specialised Therapeutics signs exclusive agreement with Ascendis Pharma A/S for ... - PR Newswire

Added to Collection on: 2024-01-07 19:19:34

Tags for this article:

Rare diseases
Peptide hormones
Growth hormones
Orphan drugs
Dwarfism
Palopegteriparatide
Growth hormone therapy
Growth hormone
Hypoparathyroidism
Achondroplasia
Parathyroid hormone
Parathyroid gland
Ascendis Pharma A/S
Ascendis Pharma
hGH

Click the tags to see associated articles and topics

View Article Details
Ascendis Pharma A/S (NASDAQ:ASND) Given New $140.00 Price Target at Morgan Stanley

Added to Collection on: 2024-05-18 16:53:59

Tags for this article:

Equity securities
Corporate finance
Financial capital
Private equity
Stock
Stock market
Kite Pharma
Zealand Pharma
Ascendis Pharma A/S
Ascendis Pharma

Click the tags to see associated articles and topics

View Article Details
Latham & Watkins Advises Ascendis Pharma in US $150 Million Royalty Financing

Added to Collection on: 2024-09-04 22:18:55

Tags for this article:

Expense
Intellectual property law
Patent law
Royalty payment
Royalty fund
Royalty Pharma plc
Ascendis Pharma A/S
Ascendis Pharma

Click the tags to see associated articles and topics

View Article Details
Book a Demo